A Phase 1 trial shows a personalized DNA vaccine (GNOS-PV01) is safe and doubles survival rates for aggressive glioblastoma.

Survival rate surpasses historical outcomes in a small phase I study ...

Interim results from the first three brain cancer patients treated; two of whom demonstrated complete response, with total disappearance of all ...

All types of brain cancers collectively have a five-year survival rate of just 33%, according to the National Cancer ...

Promising trial results: A personalized DNA vaccine for glioblastoma doubled two-year survival rates in a small phase 1 trial and showed no serious side effects. How it works: The vaccine targets up ...

A next-generation cancer therapy being developed at McMaster University has shown early promise as a treatment candidate for ...

Jason Collins, the first openly gay NBA player, has died at 47 after an eight-month battle with glioblastoma, leaving a ...

A next-generation cancer therapy being developed at McMaster University has shown early promise as a treatment candidate for glioblastoma, the most aggressive and most common type of primary brain ...

Jason Collins, the NBA’s first openly gay player who went on to become a pioneer for inclusion and an ambassador for the ...

Participants in a clinical trial lived longer years longer after increased immune response to glioblastoma slowed progression ...